Mounjaro 10mg vs Wegovy: Treatment Comparison Guide
Understanding Mounjaro 10mg Equivalent to Wegovy Prescription Weight Loss Options
When considering Mounjaro 10mg equivalent to Wegovy, it's important to understand that these are fundamentally different medications with distinct mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that works on specific brain appetite centres to reduce hunger and increase satiety signals. Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors, offering a dual-hormone approach to appetite regulation and glucose metabolism.
Both prescription-only medicines are designed to support weight management in adults with a BMI of 30 or above, or BMI 27 or above with weight-related health conditions such as high blood pressure or type 2 diabetes. The choice between these treatments depends on individual patient factors, medical history, and prescriber assessment. At EverydayMeds, our clinical team can help determine which option may be most suitable following a comprehensive online consultation and review of your medical background.
Wegovy Pricing Structure and Bundle Options for Weight Management
Understanding the cost comparison between Mounjaro 10mg equivalent to Wegovy helps inform treatment decisions. Wegovy follows a structured dose escalation protocol starting at £79.99 for the 0.25mg starter dose (weeks 1-4), progressing to £94.99 for 0.5mg (weeks 5-8), then £99.99 for 1mg (weeks 9-12). The therapeutic doses continue at £139.99 for 1.7mg (weeks 13-16) and reach the maintenance dose of 2.4mg at £209.99 from week 17 onwards. New customers benefit from applying code FIRST40 at checkout, whilst returning customers can use code DOSE25.
Our bundled options provide convenient multi-month supply arrangements without requiring separate orders. The Intro Duo combines 0.25mg and 0.5mg doses for £169.99, covering your first 8 weeks of treatment. The Progress Trio includes 0.5mg, 1mg, and 1.7mg doses for £369.99, supporting gradual escalation over 12 weeks. For maintenance therapy, the Ultimate Stability Trio provides three months of 2.4mg doses for £649.99, ensuring consistent supply during your established treatment phase.
Clinical Evidence Supporting Mounjaro 10mg Equivalent to Wegovy Comparisons
Both medications have demonstrated efficacy in separate clinical trial programmes, though direct head-to-head comparisons are limited due to different study designs and populations. Wegovy's STEP trial programme, published by Wilding et al. in NEJM 2021, showed that patients may achieve average weight reductions of approximately 15% at 68 weeks when combined with lifestyle modifications. The STEP trials enrolled over 4,500 participants across multiple studies, establishing Wegovy's role in comprehensive weight management programmes.
When evaluating Mounjaro 10mg equivalent to Wegovy through clinical evidence, both treatments require integration with reduced-calorie diet and increased physical activity for optimal results. Individual responses may vary significantly, and weight management outcomes depend on multiple factors including baseline BMI, adherence to lifestyle changes, and duration of treatment. Our prescribers review individual medical histories to assess suitability for either treatment option.
How Wegovy Works as a GLP-1 Receptor Agonist
Wegovy's mechanism involves mimicking the action of GLP-1, a naturally occurring incretin hormone that regulates appetite and glucose metabolism. When administered as a once-weekly subcutaneous injection, semaglutide binds to GLP-1 receptors in the brain's hypothalamus, potentially reducing appetite signals and increasing feelings of fullness after meals. This may lead to reduced caloric intake and support weight management efforts when combined with appropriate dietary changes. The medication may also slow gastric emptying, contributing to prolonged satiety between meals. Unlike some weight management approaches, Wegovy works through established physiological pathways rather than stimulant mechanisms.
Simple Online Assessment and Prescription Process
Accessing either Mounjaro 10mg equivalent to Wegovy through EverydayMeds begins with our streamlined 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Our qualified prescribers review each application within 3 working days (or 24 hours with express service) to ensure treatment appropriateness and safety. Once approved, medications are dispatched via next-day cold-chain delivery maintaining the required 2-8°C temperature throughout transit. Our GPhC-registered pharmacy (#9012878) ensures all regulatory requirements are met from prescription to delivery. Regular follow-up consultations help monitor progress and adjust treatment as needed throughout your weight management journey.
Storage Requirements and Practical Treatment Considerations
Wegovy FlexTouch pens require refrigerated storage at 2-8°C before first use, but offer practical advantages for active lifestyles with up to 6 weeks of room temperature stability below 30°C once removed from refrigeration. This compares favourably to Mounjaro's 21-day room temperature limit, making Wegovy potentially more convenient for travel or varying schedules. The dose escalation protocol cannot be accelerated, requiring gradual increases over 16 weeks to reach the maintenance 2.4mg dose. Each pen delivers exactly one dose through the user-friendly FlexTouch injection system. Injection sites should be rotated between thigh, abdomen, and upper arm to prevent lipodystrophy. The once-weekly administration schedule helps maintain consistent medication levels whilst supporting treatment adherence.
Prescription Weight Loss: Regulatory Framework and Clinical Oversight
When comparing Mounjaro 10mg equivalent to Wegovy for prescription weight loss, both treatments fall under strict MHRA regulation as prescription-only medicines requiring clinical assessment and ongoing supervision. NICE guidance TA875 recommends Wegovy specifically for eligible adults within specialist weight management services, emphasising the importance of comprehensive lifestyle support alongside pharmacological intervention. Our prescribers ensure compliance with current prescribing guidelines whilst providing accessible treatment pathways for appropriate candidates.
The prescription weight loss landscape requires careful consideration of contraindications, drug interactions, and individual patient factors that influence treatment selection. Both Wegovy and Mounjaro carry MHRA additional monitoring status (Black Triangle ▼), reflecting their relatively recent approval and continued safety surveillance. Regular clinical review helps optimise treatment outcomes whilst monitoring for potential adverse effects or the need for dose adjustments throughout the weight management programme.
Start Your Prescription Weight Loss Journey Today
Both Wegovy and Mounjaro are available through EverydayMeds following clinical assessment, with your prescriber helping determine which treatment aligns best with your individual needs and medical history. New customers can apply code FIRST40 at checkout, whilst returning patients benefit from code DOSE25 for continued treatment. Our comprehensive service includes initial consultation, ongoing prescriber support, and reliable cold-chain delivery ensuring medication integrity from our registered pharmacy to your door. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and take the first step toward medically-supervised weight management. Remember that sustainable weight management requires commitment to dietary changes and increased physical activity alongside any prescribed medication.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
